Effects of Intravenous Administration of Fibrinolysin (Plasmin) in Man-Reference-Cited by-同舟云学术

Effects of Intravenous Administration of Fibrinolysin (Plasmin) in Man

Published:1959-07 Issue:1 Volume:20 Page:42-55
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

MOSER KENNETH M.¹

Affiliation:

1. From the Enzyme Research Laboratory, District of Columbia General Hospital; and the Department of Medicine, Georgetown University Medical School, Washington, D. C.

Abstract

The potentiality of dissolving clots has aroused great interest in fibrinolysin (plasmin) as a therapeutic agent in thromboembolism. In this paper the effects of intravenous administration of purified fibrinolysin in man are reported, with special emphasis upon systemic toxicity and alterations in clotting factors and fibrinolytic activity. This information is necessary for the evaluation of this agent for clinical purposes.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.20.1.42

Reference40 articles.

1. The effect of heparin in experimentally produced venous thrombosis;RABINOVITCH J.;Surgery,1953

2. WRIGHT H. D. KUBIK _M. M. AND HAYDEN A.: Recanalization of tlhrombosed arteries under anticoagulant therapy. Brit. M1. J. 1: 1021 1953.

3. Influence of anticoagulant administration on the rate of recanalization of experimentally thrombosed veins

4. THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSIS

5. Studies on a proteolytie enzynie systenm of the blood: V. Activation of profibrinolysin by trypsin;LEWIS J. H.;Amn. J. Physiol.,1952

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acid-Stabilized Plasmin as a Novel Direct-Acting Thrombolytic;Production of Plasma Proteins for Therapeutic Use;2012-12-14

2. Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers;Clinical Therapeutics;2009-08

3. THERAPY STIMULATING THE FIBRINOLYTIC SYSTEM;Scandinavian Journal of Haematology;2009-04-24

4. Structure and activity of plasmin and other direct thrombolytic agents;Thrombosis Research;2008-01

5. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?;Trends in Pharmacological Sciences;2004-02